Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• The protein p21 is known for its tumor-suppressive functions, including cell cycle arrest.
• Recent studies highlight p21's pro-oncogenic activities, suggesting an "antagonistic duality" in cancer progression.
• The role of p21 in regulating autophagy remains largely unexplored.

Purpose of the Study:

• To investigate the role of p21 in regulating basal autophagy.
• To elucidate the mechanism underlying p21-mediated autophagy modulation.
• To understand the dual role of p21 in early tumor development versus established tumors.

Main Methods:

• Cellular senescence and proliferation assays.
• Western blotting to assess protein levels (p21, Akt, autophagy markers).
• Reactive Oxygen Species (ROS) detection and quantification.

Main Results:

• p21 negatively regulates basal autophagy at physiological concentrations.
• p21 attenuation leads to Akt activation, ROS accumulation, and subsequent modulation of autophagy.
• p21 exhibits oncogenic activity in early tumor development by inhibiting autophagy, while its inhibition promotes cancer cell survival in established tumors.

Conclusions:

• Autophagy plays a critical role in the antagonistic functional duality of p21 in cancer.
• p21's regulation of autophagy offers potential therapeutic targets for cancer treatment.
• Understanding p21's complex role in autophagy is crucial for cancer therapy strategies.